169 related articles for article (PubMed ID: 21514865)
1. [Survival following liver transplant due to imatinib-induced acute liver failure: a case study].
García-Valdés M; Miras López M; Garrido Corro B; De La Rubia Nieto A
Farm Hosp; 2012; 36(1):50-1. PubMed ID: 21514865
[No Abstract] [Full Text] [Related]
2. [Fulminating hepatitis for imatinib in a patient with chronic myeloid leukaemia].
Martínez Pascual C; Valdés Mas M; de la Peña Moral JM; Miras López M
Med Clin (Barc); 2011 Sep; 137(7):329-30. PubMed ID: 21074222
[No Abstract] [Full Text] [Related]
3. Update on practical aspects of the treatment of chronic myeloid leukemia with imatinib mesylate.
Zonder JA; Schiffer CA
Curr Hematol Malig Rep; 2006 Sep; 1(3):141-51. PubMed ID: 20425345
[TBL] [Abstract][Full Text] [Related]
4. Early imatinib-mesylate-induced hepatotoxicity in chronic myelogenous leukaemia.
Kong JH; Yoo SH; Lee KE; Nam SH; Kwon JM; Lee SM; Chang HJ; Choi MY; Cho MS; Mun YC; Nam E; Lee SN; Seong CM
Acta Haematol; 2007; 118(4):205-8. PubMed ID: 18030002
[TBL] [Abstract][Full Text] [Related]
5. Cocaine abuse may influence the response to imatinib in CML patients.
Breccia M; Gentilini F; Alimena G
Haematologica; 2007 Mar; 92(3):e41-2. PubMed ID: 17405756
[No Abstract] [Full Text] [Related]
6. Imatinib and Panax ginseng: a potential interaction resulting in liver toxicity.
Bilgi N; Bell K; Ananthakrishnan AN; Atallah E
Ann Pharmacother; 2010 May; 44(5):926-8. PubMed ID: 20332334
[TBL] [Abstract][Full Text] [Related]
7. Imatinib mesylate: a new pill for chronic myelogenous leukemia.
Parmar KK; King RS
Cancer Pract; 2001; 9(5):263-5. PubMed ID: 11879324
[No Abstract] [Full Text] [Related]
8. Imatinib mesylate (gleevec) hepatotoxicity.
Mindikoglu AL; Regev A; Bejarano PA; Martinez EJ; Jeffers LJ; Schiff ER
Dig Dis Sci; 2007 Feb; 52(2):598-601. PubMed ID: 17219077
[No Abstract] [Full Text] [Related]
9. Reduced dose of imatinib for patients with chronic myeloid leukemia and low body surface area.
Park SJ; Choi IK; Seo HY; Sung HJ; Park KH; Kim SJ; Oh SC; Seo JH; Choi CW; Kim BS; Shin SW; Kim YH; Kim JS
Acta Haematol; 2007; 118(4):219-21. PubMed ID: 18057867
[No Abstract] [Full Text] [Related]
10. [Imatinib mesylate-induced acute cytolytic hepatitis].
Rocca P; El Jastimi S; Troncy J; Scoazec JY; Boucher A; Vial T; Trépo C; Zoulim F
Gastroenterol Clin Biol; 2004 Oct; 28(10 Pt 1):918-9. PubMed ID: 15523233
[No Abstract] [Full Text] [Related]
11. Histological features of acute hepatitis after imatinib mesylate treatment.
James C; Trouette H; Marit G; Cony-Makhoul P; Mahon FX
Leukemia; 2003 May; 17(5):978-9. PubMed ID: 12750713
[No Abstract] [Full Text] [Related]
12. [Severe imatinib-induced hepatotoxicity].
García Hernández FJ; González León R; Castillo Palma MJ; Sánchez Román J
Med Clin (Barc); 2012 May; 138(14):638; author reply 638-9. PubMed ID: 22137996
[No Abstract] [Full Text] [Related]
13. Nilotinib in a patient with postnecrotic liver cirrhosis related to imatinib.
Spataro V
J Clin Oncol; 2011 Jan; 29(3):e50-2. PubMed ID: 20956624
[No Abstract] [Full Text] [Related]
14. Imatinib mesylate.
Am J Health Syst Pharm; 2001 Dec; 58(23):2241-2. PubMed ID: 11765724
[No Abstract] [Full Text] [Related]
15. Successful management of liver injury caused by imatinib mesylate in a patient with previously untreated chronic myelogenous leukemia in the chronic phase.
Yamazaki R; Okamoto S; Chen CK; Tada S; Saito H; Shibata R; Sakamoto M; Mori T; Ikeda Y
Leuk Lymphoma; 2006 Jul; 47(7):1427-30. PubMed ID: 16923586
[No Abstract] [Full Text] [Related]
16. Imatinib mesylate-induced acute liver failure in a patient with gastrointestinal stromal tumors.
Tonyali O; Coskun U; Yildiz R; Karakan T; Demirci U; Akyurek N; Benekli M; Buyukberber S
Med Oncol; 2010 Sep; 27(3):768-73. PubMed ID: 19662540
[TBL] [Abstract][Full Text] [Related]
17. Imatinib mesylate in the treatment of hematologic malignancies.
Piccaluga PP; Rondoni M; Paolini S; Rosti G; Martinelli G; Baccarani M
Expert Opin Biol Ther; 2007 Oct; 7(10):1597-611. PubMed ID: 17916051
[TBL] [Abstract][Full Text] [Related]
18. Imatinib mesylate induced immune thrombocytopenia.
Rajappa S; Varadpande L; Paul TR; Digumarti R
Leuk Lymphoma; 2007 Nov; 48(11):2261-3. PubMed ID: 17926182
[No Abstract] [Full Text] [Related]
19. Nilotinib post-liver transplantation for acute hepatic failure related to imatinib.
Perini GF; Santos FP; Funke V; Ruiz J; Neto BH; Hamerschlak N
Leuk Res; 2009 Dec; 33(12):e234-5. PubMed ID: 19632720
[TBL] [Abstract][Full Text] [Related]
20. Massive bone marrow necrosis in a patient with chronic myelocytic leukemia following imatinib mesylate therapy.
Tamura T; Tasaka T; Fujimoto M; Matsuhashi Y; Fukumot T; Mano S; Kuwajima M; Nagai M
Haematologica; 2004 Sep; 89(9):ECR32. PubMed ID: 15377484
[No Abstract] [Full Text] [Related]
[Next] [New Search]
